Although APOE4 was found to be significantly associated with memory function in non-dementia elderly individuals [19], APOE genotyping remains the most common risk factor utilised to test for sporadic AD risk, and in clinical diagnosis [11,42,43]. This evidence concerns the gene APOE and Alzheimer disease.